Jul 23, 2019
Alnylam Launches ONPATTRO® (patisiran) for the Treatment of Polyneuropathy in hATTR Amyloidosis, the First-Ever RNAi Therapeutic Approved in Canada
Jun 19, 2019
ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
Jun 05, 2019
ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium
May 28, 2019
ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of Tau
May 21, 2019
New U.S. Patents Granted for RegenLab
May 06, 2019
FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin-mediated amyloidosis
Apr 23, 2019
HealthWell Foundation Opens New Amyloidosis Fund to Assist Patients with Treatment Costs
Apr 23, 2019
ProMIS Neurosciences to Participate in the Think Equity Investor Conference
Mar 26, 2019
Leading Experts Publish a Roadmap for Critical Areas of Research in Amyloidosis
Mar 25, 2019
Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials
Mar 21, 2019
Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's Disease
Mar 13, 2019
SCMR Partners with Foundation to Promote March as Amyloidosis Awareness Month
Feb 21, 2019
ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors
Feb 05, 2019
McCord Research Identifies Olive Compounds that May Act Against Alzheimer's Disease
Jan 31, 2019
Selectivity for the Toxic Oligomer Essential to Treating Root Cause of Alzheimer's Disease
Jan 17, 2019
ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences
Dec 18, 2018
ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek
Dec 17, 2018
ProMIS Neurosciences Appoints Renowned Neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board
Nov 26, 2018
Never-before-seen DNA recombination in the brain linked to Alzheimer's disease
Nov 20, 2018
ProMIS Neurosciences Issues Year-to Date Update, Highlighting 2018 Accomplishments